Verstovsek, S., Mesa, R. A., Gotlib, J., Gupta, V., DiPersio, J. F., Catalano, J. V., . . . Kantarjian, H. (2017). Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial. J Hematol Oncol.
Citación estilo ChicagoVerstovsek, Srdan, et al. "Long-term Treatment With Ruxolitinib for Patients With Myelofibrosis: 5-year Update From the Randomized, Double-blind, Placebo-controlled, Phase 3 COMFORT-I Trial." J Hematol Oncol 2017.
Cita MLAVerstovsek, Srdan, et al. "Long-term Treatment With Ruxolitinib for Patients With Myelofibrosis: 5-year Update From the Randomized, Double-blind, Placebo-controlled, Phase 3 COMFORT-I Trial." J Hematol Oncol 2017.